Ernexa Therapeutics Inc. Capitalized Computer Software, Accumulated Amortization
Ernexa Therapeutics Inc. (ERNA) had Capitalized Computer Software, Accumulated Amortization of $3.08 million as of 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Notes › Goodwill and Other › Capitalized Cost, Software to be Sold, Leased, or Marketed, after Accumulated Amortization
us-gaap:CapitalizedComputerSoftwareAccumulatedAmortization · last filed 2021-03-11
- 2020-12-31: Capitalized Computer Software, Accumulated Amortization $3.08M.
- 2020-09-30: Capitalized Computer Software, Accumulated Amortization $3.02M.
- 2020-06-30: Capitalized Computer Software, Accumulated Amortization $2.88M.
- 2020-03-31: Capitalized Computer Software, Accumulated Amortization $2.73M.
| Period end | Capitalized Computer Software, Accumulated Amortization |
|---|---|
| 2020-12-31 | $3.08M 10-K · filed 2021-03-11 |
| 2020-09-30 | $3.02M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $2.88M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $2.73M 10-Q · filed 2020-05-20 |
| 2019-12-31 | $3.34M 10-K · filed 2021-03-11 |
| 2019-09-30 | $3.32M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $3.17M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $3.07M 10-Q · filed 2019-05-14 |
| 2018-12-31 | $2.97M 10-K · filed 2020-03-19 |
| 2018-09-30 | $2.88M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $2.83M 10-Q · filed 2018-08-06 |
| 2018-03-31 | $2.73M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $2.65M 10-K · filed 2019-03-22 |
| 2017-09-30 | $2.58M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $2.74M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $2.70M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $2.64M 10-K · filed 2018-03-09 |
| 2016-09-30 | $2.56M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $2.47M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $2.50M 10-Q · filed 2016-05-09 |
| 2015-12-31 | $2.38M 10-K · filed 2017-03-09 |
| 2015-09-30 | $2.13M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $1.89M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $3.36M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $3.11M 10-K · filed 2016-03-15 |
| 2014-09-30 | $3.07M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $2.83M 10-Q · filed 2014-08-14 |
| 2014-03-31 | $2.59M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $2.37M 10-K · filed 2015-03-27 |
| 2013-09-30 | $2.15M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $1.98M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $1.94M 10-Q · filed 2013-05-13 |
| 2012-12-31 | $1.77M 10-K · filed 2014-03-31 |
| 2012-09-30 | $1.99M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $1.84M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $1.68M 10-Q · filed 2012-05-11 |
| 2011-12-31 | $1.58M 10-K · filed 2013-03-29 |
| 2011-09-30 | $1.46M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $1.60M 10-Q · filed 2011-08-12 |
| 2010-12-31 | $1.59M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |